(RTTNews) - Forward Air Corporation (FWRD) reported a narrower first-quarter loss despite a decline in revenue, mainly helped by lower losses from other operations.
(RTTNews) - Forward Air Corporation (FWRD) reported a narrower first-quarter loss despite a decline in revenue, mainly helped by lower losses from other operations.
Earnings Call Insights: Crinetics Pharmaceuticals (CRNX) Q1 2026 Management view "This collective effort has translated into 232 additional patient enrollments and $10.3 million in net product revenue for the quarter," said (Founder, President, CEO & Director R. Struthers), while adding, "we continue to see momentum build on all fronts in the second quarter." Struthers tied early launch execution ...
Earnings Call Insights: Crinetics Pharmaceuticals (CRNX) Q1 2026 Management view "This collective effort has translated into 232 additional patient enrollments and $10.3 million in net product revenue for the quarter," said (Founder, President, CEO & Director R. Struthers), while adding, "we continue to see momentum build on all fronts in the second quarter." Struthers tied early launch execution to longer-term positioning, saying, "Palsonify sets a new standard of care for the treatment of acromegaly and is on track to become the most prescribed brand," and highlighted international regulatory activity: "the European Commission approval of our MAA, the JNDA submission in Japan by our partners at SKK and our MAA submission in Brazil." (Chief Commercial Officer Isabel Kalofonos) described demand mix and prescribing breadth: "the majority of new enrollments continue to come from patients switching from existing therapies," and "treatment-naive patients increased from 5% to 15% of total enrollments" from Q4 2025 to Q1 2026. Kalofonos also pointed to access and payer progress: "approximately 70% of patients on therapy at the end of first quarter were reimbursed," and "we have now achieved over 60% coverage and remain on track to exceed our 75% coverage goal by the end of third quarter of 2026." (Chief Financial Officer Tobin Schilke) framed spending and runway, saying, "we recognized $10.7 million in total revenue," "research and development expenses for the first quarter were $100.1 million," and "we project that our existing cash and investments will be sufficient to fund our operations into 2030." Outlook Schilke said, "we are maintaining our guidance for GAAP and non-GAAP operating expenses in 2026," specifying "GAAP operating expenses to be between $600 million and $650 million" and "non-GAAP operating expenses... to be between $480 million and $520 million." On the commercial trajectory, (CFO Schilke) avoided a form-volume forecast, saying, "it's really tricky to ...
Earnings Call Insights: Gevo (GEVO) Q1 2026 Management View “This quarter was about advancing execution and strengthening the foundation for scale,” said CEO, President & Director Paul Bloom, adding, “The first quarter of 2026 was our fourth consecutive quarter delivering positive non-GAAP adjusted EBITDA and reflected better-than-expected results with improved margins on top of solid production v...
Earnings Call Insights: Gevo (GEVO) Q1 2026 Management View “This quarter was about advancing execution and strengthening the foundation for scale,” said CEO, President & Director Paul Bloom, adding, “The first quarter of 2026 was our fourth consecutive quarter delivering positive non-GAAP adjusted EBITDA and reflected better-than-expected results with improved margins on top of solid production volumes.” Bloom highlighted monetization from carbon and low-carbon ethanol, saying, “In Q1, we sold approximately 57% of our carbon attributes attached to fuel,” and “We also generated nearly 20,000 tons of engineered carbon dioxide removal credits or CDRs we sold into the voluntary carbon market.” On profitability targets, Bloom said, “For 2026, we expect approximately $30 million of adjusted EBITDA as we progress towards our previously stated target of achieving $40 million of adjusted EBITDA on an annualized run rate basis from existing operations by the end of this year,” and introduced “a corporate-wide initiative we’re calling the EBITDA challenge.” On Project North Star financing strategy changes, Bloom said, “We made the decision to withdraw from the DOE financing process,” citing “certain new requirements for the loan guarantee, including enhanced oil recovery as a business objective,” and added, “We have received nonbinding indications of interest from multiple lenders, which supports our goal of securing financing for Project North Star by the end of 2026.” CFO Oluwagbemileke Agiri reported, “During the first quarter of 2026, we reported revenue of $43 million,” and “net loss attributable to Gevo of $22 million or $0.09 per share,” while noting, “first quarter results include debt extinguishment and modification of $11 million and non-GAAP adjusted EBITDA of $9 million.” Outlook Bloom reiterated near-term operating targets, saying, “For 2026, we expect approximately $30 million of adjusted EBITDA,” and “reaffirm”ed “our previously stated target of achieving $40 m...
Earnings Call Insights: BioLife Solutions (BLFS) Q1 2026 Management view "We're off to a solid start to 2026 with first quarter revenue growth of 25% and adjusted EBITDA up approximately 15% versus the prior year," said CEO & Chairman Roderick de Greef. "Total revenue reached $27.5 million" and "adjusted EBITDA of $6.2 million or 22% of revenue" as "BPM remained the primary driver of revenue growt...
Earnings Call Insights: BioLife Solutions (BLFS) Q1 2026 Management view "We're off to a solid start to 2026 with first quarter revenue growth of 25% and adjusted EBITDA up approximately 15% versus the prior year," said CEO & Chairman Roderick de Greef. "Total revenue reached $27.5 million" and "adjusted EBITDA of $6.2 million or 22% of revenue" as "BPM remained the primary driver of revenue growth," said CEO & Chairman de Greef. "BPM represents over 85% of total revenue" and the company said it "maintain[s] a dominant market share," with "more than 250 commercially sponsored CGT clinical trials in the U.S., exceeding a 70% market share" and BPM "embedded in 17 approved therapies," said CEO & Chairman de Greef. "Gross margin and adjusted EBITDA as a percent of revenue declined year-over-year due to the previously discussed bag yield dynamics," and management said it is "confident that this is temporary in nature," said CEO & Chairman de Greef. "We are affirming the guidance we introduced on our last call" and "anticipate generating full year GAAP net income for the first time in many years," said CEO & Chairman de Greef. "We reported Q1 revenue of $27.5 million, representing an increase of 25% year-over-year," said CFO Troy Wichterman. "GAAP gross margin for Q1 2026 was 64% compared with 67% in Q1 2025" and "Adjusted gross margin for the first quarter was 64% compared with 68% in the prior year," said CFO Wichterman. Outlook "We expect revenue of $112.5 million to $115 million for the year, representing growth of 17% to 20%," said CEO & Chairman de Greef. "We are affirming the guidance we introduced on our last call" and "expect continued operating and adjusted EBITDA margin expansion," said CEO & Chairman de Greef. "We expect GAAP and adjusted gross margin for the full year to be in the mid-60s" and "expect to achieve full year positive GAAP net income and expansion of adjusted EBITDA margin in 2026 compared to 2025," said CFO Wichterman. The company’s bag-yield re...
Earnings Call Insights: Core Molding Technologies (CMT) Q1 2026 Management View “Our first quarter of 2026 was a busy one,” said Chief Operating Officer Eric Palomaki, highlighting “$17 million in additional new wins,” “relocating 5 of 9 presses into our new facility in the Monterrey,” and “posting our best gross margin quarter in over a decade.” On leadership transition, Chief Operating Officer P...
Earnings Call Insights: Core Molding Technologies (CMT) Q1 2026 Management View “Our first quarter of 2026 was a busy one,” said Chief Operating Officer Eric Palomaki, highlighting “$17 million in additional new wins,” “relocating 5 of 9 presses into our new facility in the Monterrey,” and “posting our best gross margin quarter in over a decade.” On leadership transition, Chief Operating Officer Palomaki said, “As I fully transition into the CEO role this month, we have taken deliberate steps to reinforce operational leadership and continuity,” adding, “We have split the COO role into 2 positions,” with “Arnold Alanis now leads our Mexico operations and Mike Gayford oversees the U.S. and Canada operations.” On end-market mix and new wins, Chief Operating Officer Palomaki said the quarter’s awards included “a significant multiyear battery energy storage system project,” and added, “While battery adoption has moderated in consumer EVs, demand is expanding rapidly in grid infrastructure.” CFO Alex Panda framed the quarter as truck-cycle driven on sales but margin-strong, saying, “As expected, first quarter revenues declined by 4.7% year-over-year, driven primarily by previously discussed truck cycle dynamics,” while “we delivered strong gross margins of 20.4%.” Outlook CFO Panda reaffirmed the company’s fiscal 2026 framework: “total sales to be flat to up approximately 5% with tooling revenue weighted toward the fourth quarter,” and “full year gross margins in the range of 17% to 19%.” CFO Panda detailed the temporary cost items management expects to track through the first half: “The company incurred $2.1 million of Mexico expansion-related expense during the first quarter and expects to incur approximately $900,000 in the second quarter,” and “incurred $924,000 of succession planning related costs and expects to incur approximately $900,000 more over the balance of 2026, primarily in the second quarter.” On macro timing, Chief Operating Officer Palomaki said, “we exp...
Earnings Call Insights: Ispire Technology (ISPR) Q3 fiscal 2026 Management View "This quarter marked a turning point for Ispire. Our business has stabilized," said Co-CEO & President of Aspire North America Michael Wang, adding, "we ended the quarter with $18 million in cash, up $468,000 sequentially" and that the company’s "confidence in becoming cash flow positive in the second half of this cale...
Earnings Call Insights: Ispire Technology (ISPR) Q3 fiscal 2026 Management View "This quarter marked a turning point for Ispire. Our business has stabilized," said Co-CEO & President of Aspire North America Michael Wang, adding, "we ended the quarter with $18 million in cash, up $468,000 sequentially" and that the company’s "confidence in becoming cash flow positive in the second half of this calendar year 2026" was reinforced by the sequential cash increase. "Our Malaysia manufacturing platform is live today," Wang said, calling it "one of the most strategically important developments in the company's history" and stating, "Malaysia provides us with an estimated 25% tariff advantage over China" as Ispire pursues opportunities in "the $73 billion global vape market." "Plans are underway to launch our Vapor ODM initiative in July," Wang said, adding that it "will initially serve small and mid-sized brands with larger brand opportunities targeted for 2027." On longer-duration initiatives, Wang said, "we believe our Age-Gating platform has the potential to help unlock approximately $50 billion to $70 billion U.S. flavored vape market" and that G-Mesh Glass Technology is drawing interest in "a $24 billion plus legal global market, including licensing discussions with major tobacco participants." "For the fiscal third quarter ended March 31, 2026, Ispire reported revenue of $18.7 million" and "gross margin was 10.7%," said Chief Financial Officer Jie Yu. Yu also highlighted a one-time item: "gross profit was impacted by approximately $2.2 million of one-time product returns from legacy cannabis customer with whom we have ceased doing business," adding, "We view those returns as part of final cleanup associated with our strategic repositioning." Outlook "We ended the quarter with $18 million in cash" and "reinforces our confidence in becoming cash flow positive in the second half of this calendar year 2026," Wang said; Yu similarly stated the cash balance "underpin our co...
British Airways owner IAG SA said profit and free cash flow for the year will be lower than anticipated because of a higher fuel bill driven by soaring oil prices from the Middle East war. The company expects its fuel cost to amount to about €9 billion this year based on the fuel curve as of May 5, it said on Friday. While the airline group aims to to generate “significant” free cash flow in the y...
British Airways owner IAG SA said profit and free cash flow for the year will be lower than anticipated because of a higher fuel bill driven by soaring oil prices from the Middle East war. The company expects its fuel cost to amount to about €9 billion this year based on the fuel curve as of May 5, it said on Friday. While the airline group aims to to generate “significant” free cash flow in the year but, it will be less than the €3 billion guided in February, IAG said. Capital spending will be about €3.5 billion, compared with a previous target of about €3.6 billion, IAG said. “In the longer term we expect the current situation to reinforce IAG’s leadership position and resilient earnings power in a more consolidated, sustainable airline market.,” the company said. Higher fuel costs stemming from the Middle East war have curbed airline earnings this quarter, muting profit outlooks and forcing carriers to rein in costs . Airlines canceled flights, eliminated routes and decommissioned older, fuel-guzzling aircraft to help absorb the blows. IAG is the last of the major airline groups to report earnings this quarter following Deutsche Lufthansa AG and Air France-KLM , which both reported rising fuel bills . Lufthansa’s strategy to offset the increases included shutting down regional subsidiary CityLine.